^{Words by Chris Coleman-Brown, CEO and Founder, Cureoscity, London, UK}

No other real estate sector has the opportunity that life sciences real estate does when it comes to embedding technology into its approach. Unlike more traditional real estate uses, which are often hampered by longstanding embedded legacy issues, science-related real estate is writing its own rule book, built on a platform of constant tech evolution. With the industry total valuation set to surpass $3 trillion by 2030, life science occupiers are underpinning their own individual performance, growth, and innovation by utilising tech to underpin their operational delivery within demised spaces. Success is being powered by technology to deliver exceptional results when it comes to accelerating research and development, improving data management and collaboration and enhancing manufacturing capabilities and quality control.

With the market continuously growing and the availability of laboratory space becoming more prevalent, we are now in a unique opportunity phase for owners and developers of life science spaces to differentiate their campuses and provide the most captivating locations for life science occupier talent. The ultimate win is the enhanced rental income and yields as their places are selected as the preferred locations for the best and expanding science enterprises.

Up until recently, traditional commercial offices, business parks and campus locations have experienced little technological change; however, the tide has now turned. Leading destinations have embraced technology solutions to realise their asset vision and deliver the best possible end-user customer and occupier experience.

Innovations include eliminating plastic passes and implementing permission-based location mobile access for talent and their visitors, embracing smart solutions to enhance sustainability and green travel solutions, and facilitating connectivity between individuals with amenity, food and beverage and service solutions.

To ensure your destinations leverage the benefits that technology has to offer, project teams need to understand three fundamental principles:

• It’s never too early to talk tech
  
  Far too often technology is an afterthought. Once the vision for an asset is established, project teams should proactively engage in technology discussions to guide base-build provider selections, establish protocols and prevent individual development project limitations from becoming future obstacles to achieving a fully connected asset approach.
  
  

• There are no silver bullet solutions
  
  A successful tech strategy is the convergence of multiple partners working in collaboration to deliver a simple, smart and seamless experience for respective customer profiles, with variation enabled to meet the different levels of connectivity and ability to consume the information they require. Open-source connectivity is key to delivering day-one value and an ecosystem for future-proofed performance.
  
  

• Cost-effectiveness is key
  
  Science-related real estate is in the unique position to benefit from the research and development pathway that the wider real estate industry has seen with the emergence of proptech over the last decade. Timely discussion around appropriate investment across capital expenditure elements, to deliver best-fit solutions plus what can be passed through to service charge recoverable budgets long term is key to achieving appropriate solutions that underpin place performance.

Cureoscity

Cureoscity, an independent business owned by Grosvenor Hill Ventures, Savills' proptech investment subsidiary. Cureoscity connects people and buildings through technology. Through our web portal, Cureoscity provides occupiers, building and property managers with effective tools for core operational processes. Cureoscity is used across more than 1,200 individual destinations, covering over 200 million square feet. We take pride in our esteemed client partners, including Stanhope, Mitsui Fudosan, Mitsubishi Estates, The Valesco Group, Tristan Capital Partners, BEAM and numerous others.

_{Read the articles within Spotlight: Life Sciences – Trends & Outlook below.}